Insider · CIK 0001507502

Kaldor Stephen W

Reports to the SEC for 3 companies · MORRISVILLE, NC

sec.gov

Transactions

Companies

Filings

CIK

0001507502

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-06-19	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2019-06-21	CRNXCrinetics Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2014-07-02	Furiex Pharmaceuticals, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7,160 sh	—	—	0
2014-07-02	Furiex Pharmaceuticals, Inc.Stock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,012 sh	—	—	0
2014-07-02	Furiex Pharmaceuticals, Inc.Stock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,825 sh	—	—	0
2014-07-02	Furiex Pharmaceuticals, Inc.Stock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.5K sh	—	—	0
2014-02-28	Furiex Pharmaceuticals, Inc.A Award	Director	AAward	+3,580 sh	—	—	7,160
2013-05-24	Furiex Pharmaceuticals, Inc.A Award	Director	AAward	+3,580 sh	—	—	3,580
2013-03-13	Furiex Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,648 sh	$13.94	+$23K	1,648
2013-03-13	Furiex Pharmaceuticals, Inc.S Sale	Director	SSale	−1,648 sh	$39.96	−$65.9K	0
2013-03-13	Furiex Pharmaceuticals, Inc.Stock Options (to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,648 sh	—	—	5,012
2013-03-12	Furiex Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+973 sh	$13.94	+$13.6K	973
2013-03-12	Furiex Pharmaceuticals, Inc.S Sale	Director	SSale	−973 sh	$40.71	−$39.6K	0
2013-03-12	Furiex Pharmaceuticals, Inc.Stock Options (to buy)M Exercise/Conversion	Director	MExercise/Conversion	−973 sh	—	—	6,660
2013-03-12	Furiex Pharmaceuticals, Inc.S Sale	Director	SSale	−973 sh	$40.71	−$39.6K	1,648
2013-03-11	Furiex Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,379 sh	$13.94	+$75K	5,379
2013-03-11	Furiex Pharmaceuticals, Inc.S Sale	Director	SSale	−5,379 sh	$41.74	−$225K	0
2013-03-11	Furiex Pharmaceuticals, Inc.Stock Options (to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,379 sh	—	—	7,633
2013-03-11	Furiex Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,000 sh	$13.94	+$112K	8,000
2013-03-11	Furiex Pharmaceuticals, Inc.S Sale	Director	SSale	−5,379 sh	$41.74	−$225K	2,621
2013-03-11	Furiex Pharmaceuticals, Inc.Stock Options (to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,000 sh	—	—	5,012
2012-05-24	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2011-10-12	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Director	AAward	+8,825 sh	—	—	8,825
2011-10-12	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Director	AAward	+8,825 sh	—	—	8,825
2011-05-19	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Director	AAward	+13K sh	—	—	13,012

Recent filings

Accepted (ET)
Jun 224
Kaldor Stephen W0001209191-20-038172
SEC(opens sec.gov)
Jun 254
Kaldor Stephen W0001209191-19-038896
SEC(opens sec.gov)
Jul 74
Furiex Pharmaceuticals, Inc.0001437749-14-012505
SEC(opens sec.gov)
Mar 44
Furiex Pharmaceuticals, Inc.0001437749-14-003387
SEC(opens sec.gov)
May 294
Kaldor Stephen W0001437749-13-006831
SEC(opens sec.gov)
Mar 144/A
Kaldor Stephen W0001181431-13-017026
SEC(opens sec.gov)
Mar 134
Kaldor Stephen W0001181431-13-016742
SEC(opens sec.gov)

Companies

Address

3900 PARAMOUNT PARKWAY STE 150

MORRISVILLE, NC, 27560